Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.

Autoantibody-mediated tissue destruction is among the main features of organ-specific autoimmunity. This report describes "an antibody enzyme" (abzyme) contribution to the site-specific degradation of a neural antigen. We detected proteolytic activity toward myelin basic protein (MBP) in the fraction of antibodies purified from the sera of humans with multiple sclerosis (MS) and mice with induced experimental allergic encephalomyelitis. Chromatography and zymography data demonstrated that the proteolytic activity of this preparation was exclusively associated with the antibodies. No activity was found in the IgG fraction of healthy donors. The human and murine abzymes efficiently cleaved MBP but not other protein substrates tested. The sites of MBP cleavage determined by mass spectrometry were localized within immunodominant regions of MBP. The abzymes could also cleave recombinant substrates containing encephalytogenic MBP(85-101) peptide. An established MS therapeutic Copaxone appeared to be a specific abzyme inhibitor. Thus, the discovered epitope-specific antibody-mediated degradation of MBP suggests a mechanistic explanation of the slow development of neurodegeneration associated with MS.

[1]  Roland Martin,et al.  Immunology of multiple sclerosis. , 2005, Annual review of immunology.

[2]  M. Zouali,et al.  B-lymphocytes, innate immunity, and autoimmunity. , 2005, Clinical immunology.

[3]  M. Schwab,et al.  Rapid induction of autoantibodies against Nogo‐A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  M. Sela,et al.  Immunomodulation by the copolymer glatiramer acetate , 2003, Journal of molecular recognition : JMR.

[5]  M. Murakami,et al.  Inhibition of immunoglobulin G-catalyzed hydrogen peroxide generation by dexamethasone and piroxicam. , 2003, Life sciences.

[6]  H. Ulmer,et al.  Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. , 2003, The New England journal of medicine.

[7]  N. Ruddle,et al.  Rat and Human Myelin Oligodendrocyte Glycoproteins Induce Experimental Autoimmune Encephalomyelitis by Different Mechanisms in C57BL/6 Mice1 , 2003, Journal of Immunology.

[8]  P. Lehmann,et al.  Autoreactive T cells promote post-traumatic healing in the central nervous system , 2003, Journal of Neuroimmunology.

[9]  R. Lerner,et al.  Evidence for Antibody-Catalyzed Ozone Formation in Bacterial Killing and Inflammation , 2002, Science.

[10]  O. M. Durova,et al.  Catalytic antibodies in clinical and experimental pathology: human and mouse models. , 2002, Journal of immunological methods.

[11]  Daniel Thomas,et al.  Idiotypic network mimicry and antibody catalysis: lessons for the elicitation of efficient anti-idiotypic protease antibodies. , 2002, Journal of immunological methods.

[12]  M. Moscarello,et al.  A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis. , 2002, Journal of immunological methods.

[13]  J. Correale,et al.  Oligoclonal bands and antibody responses in Multiple Sclerosis , 2002, Journal of Neurology.

[14]  S. Kaveri,et al.  The prevalence of proteolytic antibodies against factor VIII in hemophilia A. , 2002, The New England journal of medicine.

[15]  R. Hohlfeld,et al.  Immunological update on multiple sclerosis , 2001, Current opinion in neurology.

[16]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[17]  H. Hartung,et al.  The role of B cells and autoantibodies in multiple sclerosis , 2000, Annals of neurology.

[18]  W. Poewe,et al.  Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. , 1999, Brain : a journal of neurology.

[19]  S. Hauser,et al.  Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.

[20]  M. Sela,et al.  Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Landry,et al.  A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Sadler,et al.  Bovine Proenteropeptidase Is Activated by Trypsin, and the Specificity of Enteropeptidase Depends on the Heavy Chain* , 1997, The Journal of Biological Chemistry.

[23]  Dan S. Tawfik,et al.  Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity? , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  I. Smirnov,et al.  Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Bloom,et al.  Blood-brain barrier penetration and in vivo activity of an NGF conjugate. , 1993, Science.

[26]  I. Smirnov,et al.  DNA hydrolyzing autoantibodies. , 1992, Science.

[27]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.

[28]  P G Schultz,et al.  At the crossroads of chemistry and immunology: catalytic antibodies. , 1991, Science.

[29]  N. Yanagisawa,et al.  Autoantibodies to each protein fraction extracted from cerebral endothelial cell membrane in the sera of patients with multiple sclerosis , 1989, Journal of Neuroimmunology.

[30]  R. Massey,et al.  Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. , 1989 .

[31]  D. Mitchell,et al.  Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein , 1988, Journal of Neuroimmunology.

[32]  Y. Nishizuka,et al.  Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3':5'-monophosphate-dependent protein kinase. , 1985, The Journal of biological chemistry.

[33]  D. McFarlin,et al.  Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. , 1983, Journal of immunology.

[34]  B. Stollar,et al.  The antibody-enzyme analogy. Comparison of enzymes and antibodies specific for phosphopyridoxyltyrosine. , 1975, Biochemistry.